Latest 28 News in the Life Sciences Industry
PR Newswire Association LLC.
Australia's biosolutions sector could nearly triple to AUD$ 13.1 billion by 2035
30 Sep 2026
PR Newswire Association LLC.
Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis
23 Sep 2026
PR Newswire Association LLC.
Medscape and Brazilian Society of Clinical Oncology Expand Partnership to Deliver Clinically Relevant Oncology Insights
22 Sep 2026
PR Newswire Association LLC.
Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore
31 Aug 2026
PR Newswire Association LLC.
NUH RECOGNISED AMONG WORLD'S GREENEST HOSPITALS; ONLY SINGAPORE HOSPITAL AWARDED HIGHEST DISTINCTION
11 Aug 2026
PR Newswire Association LLC.
Green Science Alliance Made Quantum Dot from Sargassum and Sargassum Waste
05 Aug 2026
GlobeNewswire
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
05 Aug 2026
PR Newswire Association LLC.
AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
29 Jul 2026
PR Newswire Association LLC.
AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities
13 Jul 2026
PR Newswire Association LLC.
Wegovy® (semaglutide) label updated in Singapore with higher dose supported by STEP UP evidence
08 Jul 2026
PR Newswire Association LLC.
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
07 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A First‑of‑Its‑Kind Multi-Country Campaign Spotlights Adult Respiratory Health
30 Apr 2026
PR Newswire Association LLC.
Quest International Expands European Service Footprint with New ISO Registered Service Repair Center and Warehouse in Bornem, Belgium
22 Apr 2026
GlobeNewswire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
06 Aug 2026
GlobeNewswire
Novo Nordisk raises adjusted sales and adjusted operating profit outlook for 2026
04 Aug 2026
GlobeNewswire
Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook
04 Aug 2026
GlobeNewswire
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
31 Jul 2026
GlobeNewswire
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
21 Jul 2026
GlobeNewswire
European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU
17 Jul 2026
GlobeNewswire
Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development
16 Jul 2026
GlobeNewswire
Boehringer Ingelheim reports first-half 2026 sales growth, driven by JARDIANCE® and new product launches in the U.S.
15 Jul 2026
Upcoming Events All Events
- October 2026
- Yokohama: BioJapan
- Queensland: AusBiotech Invest
- Queensland: AusBiotech International Conference